Revvity Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Revvity Inc trades at $154.1 (market cap $16.98B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $213.76 (market cap $39.15B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 2.3× Revvity Inc's market cap, and Revvity Inc pays a 0.18% dividend while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 111 Days on average.
| RVTY | TTWO | |
|---|---|---|
Market Cap | $16.98B | $39.15B |
Volume | 1,456,900 | 2,708,429 |
Sector | Health | Technology |
52-Week High | $157.36 | $262.29 |
52-Week Low | $82.26 | $189.69 |
Typical Hold Time | 12 Days | 111 Days |
Enterprise Value | $19.30B | $40.27B |
Dividend Yield | 0.18% | — |
Signals from Pluang's Aura AI — not financial advice
Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.
The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.
Take-Two Interactive (TTWO) trades at $213.44, up 4.62% today, showing strong momentum ahead of GTA VI's November launch. The stock maintains a bullish technical signal with support at $206 and resistance at $215. Despite recent earnings volatility with a Q2 miss, analyst consensus remains overwhelmingly positive with 79% buy ratings and a $292.30 price target, representing 37% upside potential from current levels.
While TTWO faces fundamental challenges with negative net margins and elevated debt levels, the imminent GTA VI release provides significant catalyst potential. Investors should weigh the substantial growth opportunity against execution risks and current valuation metrics that price in successful game performance. The stock's trajectory will likely hinge on GTA VI's commercial success and the company's ability to return to profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →